GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Polarean Imaging PLC (LSE:POLX) » Definitions » Stock Based Compensation

Polarean Imaging (LSE:POLX) Stock Based Compensation : £0.75 Mil (TTM As of Jun. 2023)


View and export this data going back to 2018. Start your Free Trial

What is Polarean Imaging Stock Based Compensation?

Polarean Imaging's Stock Based Compensation for the six months ended in Jun. 2023 was £0.34 Mil. Its Stock Based Compensation for the trailing twelve months (TTM) ended in Jun. 2023 was £0.75 Mil.


Polarean Imaging Stock Based Compensation Historical Data

The historical data trend for Polarean Imaging's Stock Based Compensation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Polarean Imaging Stock Based Compensation Chart

Polarean Imaging Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Stock Based Compensation
Get a 7-Day Free Trial 0.20 0.24 0.35 1.36 0.99

Polarean Imaging Semi-Annual Data
Dec16 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23
Stock Based Compensation Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.26 1.09 0.57 0.41 0.34

Polarean Imaging Stock Based Compensation Calculation

Stock Based Compensation is a way corporations use stock options to reward employees. It provides executives and employees the opportunity to share in the growth of the company and, if structured properly, can align their interests with the interests of the company's shareholders and investors, without burning the company's cash on hand.

Stock Based Compensation for the trailing twelve months (TTM) ended in Jun. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was £0.75 Mil.


Polarean Imaging Stock Based Compensation Related Terms

Thank you for viewing the detailed overview of Polarean Imaging's Stock Based Compensation provided by GuruFocus.com. Please click on the following links to see related term pages.


Polarean Imaging (LSE:POLX) Business Description

Traded in Other Exchanges
Address
27-28 Eastcastle Street, London, GBR, W1W 8DH
Polarean Imaging PLC designs and manufactures medical drug-device combination companies operating in the high-resolution medical imaging market. Its only operating segment being the development and commercialization of gas polariser devices and ancillary instruments. Geographically, it derives most of the revenue from the United States of America and also has a presence in Canada and the United Kingdom. The company generates revenue from products and services such as Polarisers, Parts and Upgrades, Service and other revenue. Its product portfolio includes 9820 129Xe Hyperpolarizer, 9800 129Xe Hyperpolarizer, Polarean 3777 129Xe Hyperpolarizer Upgrade Module, Polarean 2881 Polarization Measurement Station, and others.

Polarean Imaging (LSE:POLX) Headlines

No Headlines